Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models

Systemic mastocytosis (SM) is a clinically heterogeneous disease with prognosis chiefly assigned based on World Health Organization (WHO) morphologic subclassification. We assessed the feasibility of developing contemporary risk models for SM based on clinical and integrated clinical-genetics inform...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Adv
Auteurs principaux: Pardanani, Animesh, Shah, Sahrish, Mannelli, Francesco, Elala, Yoseph C., Guglielmelli, Paola, Lasho, Terra L., Patnaik, Mrinal M., Gangat, Naseema, Ketterling, Rhett P., Reichard, Kaaren K., Hanson, Curtis A., Vannucchi, Alessandro M., Tefferi, Ayalew
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2018
Sujets:
Myeloid Neoplasia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234360/
https://ncbi.nlm.nih.gov/pubmed/30413432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026245
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires